Drugs act on central nervous system
Drugs act on central nervous system
Learning objectives: Learn about the drugs that act on central nervous system, their classification and mechanism of action
Sympathetic vs Parasympathetic nervous system
Autonomic Nervous System (ANS)
• Controls involuntary body functions like heart rate, digestion, respiration, and gland activity.
• The Autonomic Nervous System (ANS) is divided into two main divisions that work in opposition to maintain body balance (homeostasis).:
1. Sympathetic nervous system (SNS) – “fight or flight”
2. Parasympathetic nervous system (PNS) – “rest and digest”
1. Sympathetic Nervous System (SNS)
• Function: Prepares the body for stressful or emergency situations.
• Origin: Thoracolumbar region of the spinal cord (T1–L2).
• Main neurotransmitters: Acetylcholine (preganglionic), Norepinephrine (postganglionic).
• Key effects:
• Increases heart rate and force of contraction
• Dilates bronchi to improve breathing (bronchodilation)
• Constricts blood vessels in the skin and gut
• Increase blood pressure
• Dilates pupils (mydriasis)
• Reduces gastrointestinal motility and secretions, thereby, digestion and intestinal activity
• Urinary retention
• Stimulates sweat glands
• Adrenal medulla releases adrenaline for rapid response
• Increase Blood glucose (glycogenolysis, gluconeogenesis)
• Ejaculation
Neurotransmitters for Sympathetic Nervous System (SNS)
• Preganglionic: Acetylcholine (ACh)
• Postganglionic: Noradrenaline (Norepinephrine)
(Exception: sweat glands → ACh)
2. Parasympathetic Nervous System (PNS)
• Function: Conserves energy and promotes relaxation, digestion, and repair.
• Origin: Cranial nerves (III, VII, IX, X) and sacral spinal cord (S2–S4).
• Main neurotransmitter: Acetylcholine (both pre- and postganglionic).
• Key effects:
• Slows heart rate
• Constricts bronchi
• Stimulates digestion and intestinal activity
• Constricts pupils and focuses the lens for near vision
• Promotes urination
• Stimulates salivation
Neurotransmitters for Parasympathetic Nervous System (PNS)
• Preganglionic: Acetylcholine (ACh)
• Postganglionic: Acetylcholine (ACh) [Memory trick: Acetylcholine (ACh) for both in Parasympathetic Nervous System]
• Sympathetic NS→ Emergency = fight or flight → prepares for action
• Parasympathetic NS→ Peace = rest and digest → conserves energy and restores body function
Epilepsy
Epilepsy is a common chronic neurological disorder that is characterized by recurrent unprovoked seizures.
Epilepsy is a brain disorder in which clusters of nerve cells, or neurons, in the brain sometimes signal abnormally. In epilepsy, the normal pattern of neuronal activity becomes disturbed, causing strange sensations, emotions, and behaviour or sometimes convulsions, muscle spasms, and loss of consciousness. Epilepsy is a disorder with many possible causes. Anything that disturbs the normal pattern of neuron activity - from illness to brain damage to abnormal brain development - can lead to seizures. Epilepsy may develop because of an abnormality in brain wiring, an imbalance of nerve signalling chemicals called neurotransmitters, or some combination of these factors. Having a seizure does not necessarily mean that a person has epilepsy. Only when a person has had two or more seizures is he or she considered having epilepsy. EEGs and brain scans are common diagnostic test for epilepsy.
Epilepsy is a condition in which a person has recurrent seizures. A seizure is defined as an abnormal, disorderly discharging of the brain's nerve cells, resulting in a temporary disturbance of motor, sensory, or mental function.
There are many types of seizures, depending primarily on what part of the brain is involved. The term epilepsy says nothing about the type of seizure or cause of the seizure, only that the seizures happen again and again. A stricter definition of the term requires that the seizures have no known underlying cause. This may also be called primary or idiopathic epilepsy.
Episodes of abnormal electrical activity within the brain result in seizures.
The specific area of the brain affected by the abnormal electrical activity may result in a particular type of seizure.
If all areas of the brain are affected by the abnormal electrical activity, a generalized seizure may result. This means that consciousness is lost or impaired. Often all the person's arms and legs stiffen and then jerk rhythmically.
One seizure type may evolve into another during the course of the seizure. For example, a seizure may start as a partial, or focal, seizure, involving the face or arm. Then the muscular activity spreads to other areas of the body. In this way, the seizure becomes generalized.
Seizures caused by high fevers in children are not considered epilepsy. Also see children’s seizures.
Cause of Epilepsy:
It is estimated to affect one percent of the U.S. population, about 2.5 million people.
In about half of all cases no cause can be found, but
head injuries,
brain tumors,
lead poisoning,
problems in brain development before birth, and
certain genetic and infectious illnesses can all cause epilepsy.
Epilepsy occurs when nerve cells in the brain fire electrical impulses at a rate of up to four times higher than normal. This causes a sort of electrical storm in the brain, known as a seizure. A pattern of repeated seizure is referred to as epilepsy. Medication controls seizure for the majority of patients, who are otherwise healthy and able to live full and productive lives.
Basic research aims to identify viral, genetic, or other factors that cause epilepsy. These findings provide the basis for developing new and improved methods of prevention and therapy.
Is there any treatment?
Once epilepsy is diagnosed, it is important to begin treatment as soon as possible. For about 80 percent of those diagnosed with epilepsy, seizures can be controlled with modern medicines and surgical techniques. Some antiepiletic drugs can interfere with the effectiveness of oral contraceptives. In 1997, the FDA approved the vagus nerve stimulator for use in people with seizures that are not well-controlled by medication.
What is the prognosis?
Most people with epilepsy lead outwardly normal lives. While epilepsy cannot currently be cured, for some people it does eventually go away. Most seizures do not cause brain damage. It is not uncommon for people with epilepsy, especially children, to develop behavioral and emotional problems, sometimes the consequence of embarrassment and frustration or bullying, teasing, or avoidance in school and other social setting. For many people with epilepsy, the risk of seizures restricts their independence (some states refuse drivers licenses to people with epilepsy) and recreational activities. People with epilepsy are at special risk for two life-threatening conditions: status epilepticus and sudden unexplained death. Most women with epilepsy can become pregnant, but they should discuss their epilepsy and the medications they are taking with their doctors. Women with epilepsy have a 90 percent or better chance of having a normal, healthy baby.
What research is being done?
Scientists are studying potential antiepileptic drugs with goal of enhancing treatment for epilepsy. Scientists continue to study how neurotransmitters interact with brain cells to control nerve firing and how non-neuronal cells in the brain contribute to seizures. One of the most-studied neurotransmitters is GABA, or gamma-aminobutryic acid. Researchers are working to identify genes that may influence epilepsy. This information may allow doctors to prevent epilepsy or to predict which treatments will be most beneficial. Doctors are now experimenting with several new types of therapies for epilepsy, including transplanting fetal pig neurons into the brains of patients to learn whether cell transplants can help control seizures, transplanting stem cells, and using a device that could predict seizures up to 3 minutes before they begin. Researchers are continually improving MRI and other brain scans. Studies have show that in some case, children may experience fewer seizures if they maintain a strict diet - called the ketogenic diet - rich in fats and low in carbohydrates.
Partial Seizures
Partial seizures are divided into simple, complex and those that evolve into secondary generalized seizures.
Simple partial seizures are further subdivided into four categories according to the nature of their symptoms: motor, autonomic, sensory or psychological.
Motor symptoms include -
movements such as jerking and stiffening.
Sensory symptoms caused by seizures involve unusual sensations affecting any of the five senses (vision, hearing, smell, taste or touch). When simple partial seizures cause sensory symptoms only (and not motor symptoms), they are called "auras."
Autonomic symptoms affect the autonomic nervous system, which is the group of nerves that control the functions of our organs, like the heart, stomach, bladder, intestines. Therefore autonomic symptoms are things like racing heart beat, stomach upset, diarrhea, loss of bladder control.
The only common autonomic symptom is a peculiar sensation in the stomach that is experienced by some patients with a type of epilepsy called temporal lobe epilepsy. Simple partial seizures with psychological symptoms are characterized by various experiences involving memory (the sensation of deja-vu), emotions (such as fear or pleasure), or other complex psychological phenomena.
Complex partial seizures, by definition, include impairment of awareness. Patients seem to be "out of touch," "out of it" or "staring into space" during these seizures. There may also be some "complex" symptoms called automatisms. Automatisms consist of involuntary but coordinated movements that tend to be purposeless and repetitive. Common automatisms include lip smacking, chewing, fidgeting and walking.
The third kind of partial seizure is one that begins as a focal seizure and evolves into a generalized convulsive ("grand-mal") seizure.
Most patients with partial seizures have simple partial, complex partial and secondarily generalized seizures. In about two-thirds of patients with partial epilepsy, seizures can be controlled with medications. Partial seizures that cannot be treated with medications can often be treated surgically.
Classification of Epilepsy:
A. Generalized seizure:
1. Generalized clonic- tonic seizure/ Grand mal/ Major Epilepsy:
- Commonest epilepsy
- Lasts 1-2 mins
- The usual sequence is aura-cry
- Unconsciousness
- Tonic spasm of all body muscles
- Clonic jerking followed by prolonged sleep and depression of all CNS functions.
2. Absence seizure/ Petit mal/ Minor Epilepsy:
- Prevalent in children
- Lasts about 1-2 minutes
- Momentary loss of consciousness.
- Patients apparently freezes and stares in one direction
- No muscular component or little bilateral jerking
- EEG shows characteristic 3 cycle per second spike and wave pattern.
3. Atonic seizure/ Akinetic epilepsy:
- Unconsciousness with relaxation of all muscles due to excessive inability discharge.
- Patient may fall.
4. Myoclonic seizure:
- Shock like momentary contraction of muscles of a limb or the whole body.
5. Infantile spasm/ Hypsarhythmia
- Seen in infants
- Probably not a form of epilepsy
- Intermittent muscle spasm and progressive mental deterioration
- Diffuse changes in the inter-seizure EEG are noted.
Partial seizures are divided into simple, complex and those that evolve into secondary generalized seizures.
1. Simple partial seizure/ Cortical focal epilepsy:
- Lasts 0.5-1 min
- Convulsions are confined to a group of muscle or localized sensory disturbance depending on the area of cortex involved in the seizure, without loss of consciousness.
2. Complex partial seizure/ Temporal lobe epilepsy/ Psychomotor:
- Attacks of bizarre and confused behaviour
- Purposeless movement
- Emotional change lasting 1-2 min along with impairment of consciousness
- An aura proceeds
- The seizure focus is located in the temporal lobe.
3. Simple partial or complex partial seizures secondarily generalised:
- The partial seizure occurs first and evolves into generalised tonic-clonic seizures with loss of consciousness.
International Classification of Epilepsies and Epileptic Syndromes 1
1. Localization-related (focal, local, partial) epilepsies and syndromes
1.1. Idiopathic with age-related onset
A. Benign childhood epilepsy with centrotemporal spikes
B. Childhood epilepsy with occipital paroxysms
1.2. Symptomatic
2. Generalized epilepsies and syndromes
2.1. Idiopathic, with age-related onset (listed in order of age)
A. Benign neonatal familial convulsions
B. Benign neonatal convulsions
C. Benign myoclonic epilepsy in infancy
D. Childhood absence epilepsy (pyknolepsy)
E. Juvenile absence epilepsy
F. Juvenile myoclonic epilepsy (impulsive petit mal)
G. Epilepsy with grand mal seizures on awakening
2.2. Idiopathic and/or symptomatic (listed in order of age)
A. West syndrome (infantile spasms)
B. Lennox-Gastaut syndrome
C. Epilepsy with myoclonic-astatic seizures
D. Epilepsy with myoclonic absences
2.3. Symptomatic
A. Nonspecific etiology
a. Early myoclonic encephalopathy
B. Specific etiology
a. Epileptic seizures may complicate many disease states
3. Epilepsies and syndromes undetermined as to whether they are focal or generalized
3.1. With both generalized and focal seizures
A. Neonatal seizures
B. Severe myoclonic epilepsy in infancy
C. Epilepsy with continuous spike waves during slow-wave sleep
D. Acquired epileptic aphasia (Landau-Kleffner syndrome)
3.2. Without unequivocal generalized or focal features
4. Special syndromes
4.1. Situation-related seizures
A. Febrile convulsions
B. Seizures related to other identifiable situations such as stress, hormonal changes, drugs, alcohol, or sleep deprivation
4.2. Isolated, apparently unprovoked epileptic events
4.3. Epilepsies characterized by specific modes of seizure precipitation
Symptoms of Epilepsy
The following symptoms may indicate someone has epilepsy. A medical exam is advised if one or more of these symptoms are present. The symptoms include:
A convulsion with or without a fever
Short periods of blackout or confused memory
Occasional "fainting spells" in which bladder or bowel control is lost, followed by extreme fatigue
Episodes of blank staring
Brief periods of no response to questions or instructions
Sudden stiffening or falls for no apparent reason
Episodes of blinking or chewing at inappropriate times
Dazed behavior; being unable to talk or communicate for a short time
Repeated movements that look out of place or unnatural
Sudden fear, anger or panic for no reason
Odd changes in the way things look, sound, smell or feel
Muscle jerks of arms, legs or body
Clusters of swift jerking movements in babies
Conditions that may be mistaken for epilepsy:
Seizures associated with high fever
Fainting
Sleep disorders: nightmares, narcolepsy, cataplexy
Psychiatric disorders: panic attacks, fugue states, psychogenic seizures
Transient ischemic attacks (TIAs): brief interruptions of blood flow to the brain
Migraine headaches
Childhood breath-holding episodes
Practice questions
Which of the following describes the mechanism of action of Carbidopa when co-administered with Levodopa?
A. Selective irreversible inhibition of central MAO-B.
B. Direct activation of postsynaptic D₂ dopamine receptors.
C. Inhibition of peripheral dopa decarboxylase.
D. Inhibition of central dopa decarboxylase.
Hint: Consider the anatomical site where Carbidopa exerts its enzyme inhibition relative to the blood-brain barrier.
The correct answer is C. Inhibition of peripheral dopa decarboxylase. Carbidopa inhibits peripheral dopa decarboxylase without crossing the blood-brain barrier, increasing levodopa availability to the CNS.
Explanation
Carbidopa works by inhibiting the enzyme dopa decarboxylase in the peripheral tissues (outside the brain).
It cannot cross the blood-brain barrier, meaning it does not inhibit central dopa decarboxylase (ruling out option D).
By blocking peripheral conversion of Levodopa into dopamine, Carbidopa ensures that more Levodopa reaches the brain intact, while simultaneously reducing peripheral side effects like nausea and vomiting.
Why the other options are incorrect:
A (Selective irreversible inhibition of central MAO-B): This describes the mechanism of drugs like Selegiline or Rasagiline.
B (Direct activation of postsynaptic dopamine receptors): This describes dopamine agonists like Pramipexole, Ropinirole, or Bromocriptine.
Question 2
A patient taking Levodopa/Carbidopa is advised to take the medication 45 minutes before meals.
Which dietary component directly competes with Levodopa for intestinal absorption and blood-brain barrier transport?
A. High-protein meals containing leucine and isoleucine.
B. Acidic beverages like citrus juices.
C. High-fat meals.
D. High-carbohydrate foods.
Hint
Think about the structural class of molecules to which Levodopa belongs as a precursor.
The correct option is A: High-protein meals containing leucine and isoleucine. Amino acids such as leucine and isoleucine from protein-rich meals compete with levodopa for transport mechanisms across the gut and blood-brain barrier.
Explanation
Mechanism of Competition: Levodopa (L-DOPA) is chemically an amino acid. It relies on the L-type amino acid transporter (LAT1) to cross both the intestinal wall into the bloodstream and the blood-brain barrier into the brain.
The Competitors: Large neutral amino acids (LNAAs) found in high-protein foods—such as leucine, isoleucine, valine, phenylalanine, and tyrosine—utilize this exact same transporter system.
Clinical Impact: When a patient consumes a high-protein meal alongside their medication, these dietary amino acids saturate the transporters, directly competing with levodopa and significantly reducing its absorption and clinical effectiveness. Taking the medication 45 minutes before meals ensures it is absorbed before dietary proteins enter the digestive tract.
Question 3
Co-administration of Vitamin B6 (Pyridoxine) with Levodopa monotherapy causes which clinical effect?
A. Inhibition of Catechol-O-Methyl Transferase.
B. Increased peripheral breakdown of Levodopa.
C. Precipitation of severe hypertensive crisis.
D. Potentiation of central dopamine synthesis.
Hint
Consider the enzymatic role of Pyridoxine in the peripheral metabolism of Levodopa.
The correct answer is B. Increased peripheral breakdown of Levodopa. Pyridoxine (Vitamin B6) acts as an essential cofactor for the enzyme dopa decarboxylase, which accelerates the breakdown of levodopa in the bloodstream before it can reach the brain. This peripheral metabolism drastically reduces the amount of levodopa available to treat Parkinson's disease symptoms, decreasing its therapeutic effectiveness.
Explanation
• Role of Vitamin B6: Pyridoxine acts as an essential cofactor for the enzyme DOPA decarboxylase (aromatic L-amino acid decarboxylase).
• Mechanism: When given alongside levodopa monotherapy, vitamin \(B_{6}\) enhances the activity of this peripheral enzyme.
• Clinical Impact: This accelerates the conversion of levodopa into dopamine in the peripheral tissues before it can cross the blood-brain barrier. Consequently, less levodopa reaches the brain to treat Parkinson's symptoms, and peripheral side effects increase.
Question 3
Co-administration of Vitamin B6 (Pyridoxine) with Levodopa monotherapy causes which clinical effect?
A. Inhibition of Catechol-O-Methyl Transferase.
B. Increased peripheral breakdown of Levodopa.
C. Precipitation of severe hypertensive crisis.
D. Potentiation of central dopamine synthesis.
Hint
Consider the enzymatic role of Pyridoxine in the peripheral metabolism of Levodopa.
The correct answer is B. Increased peripheral breakdown of Levodopa. Pyridoxine (Vitamin B6) acts as an essential cofactor for the enzyme dopa decarboxylase, which accelerates the breakdown of levodopa in the bloodstream before it can reach the brain. This peripheral metabolism drastically reduces the amount of levodopa available to treat Parkinson's disease symptoms, decreasing its therapeutic effectiveness.
Explanation
• Role of Vitamin B6: Pyridoxine acts as an essential cofactor for the enzyme DOPA decarboxylase (aromatic L-amino acid decarboxylase).
• Mechanism: When given alongside levodopa monotherapy, vitamin \(B_{6}\) enhances the activity of this peripheral enzyme.
• Clinical Impact: This accelerates the conversion of levodopa into dopamine in the peripheral tissues before it can cross the blood-brain barrier. Consequently, less levodopa reaches the brain to treat Parkinson's symptoms, and peripheral side effects increase.
Question 4
Why does Selegiline lose its selectivity for MAO-B at high doses, and what is the primary risk associated with this loss of selectivity?
A. Blockade of D₂ receptors causing pseudoparkinsonism.
B. Inhibition of MAO-A leading to hypertensive crisis.
C. Enhanced GABA transaminase activity causing seizures.
D. Inhibition of COMT leading to severe hepatotoxicity.
The correct answer is B. Inhibition of MAO-A leading to hypertensive crisis. Recall which monoamine oxidase isoform metabolizes norepinephrine and serotonin in the gut and liver.
Explanation
Loss of Selectivity: At standard low doses, selegiline selectively inhibits MAO-B (which primarily breaks down dopamine). However, at high doses, it loses this selectivity and non-selectively inhibits MAO-A as well.
The Mechanism: MAO-A is responsible for metabolizing dietary amines like tyramine in the gut and liver.
The Risk: When MAO-A is blocked, consuming tyramine-rich foods (such as aged cheeses or cured meats) prevents tyramine from being broken down. This leads to a massive release of norepinephrine, resulting in a dangerous, life-threatening spike in blood pressure known as a hypertensive crisis (commonly called the "cheese effect").
Wilson & Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry.
Edited by Charles Owens Wilson, Ole Gisvold, John H. Block, John M. Beale; Lippincott Williams & Wilkins, 2003
An Introduction to Medicinal Chemistry,
Graham L. Patrick
4th Edition, 2009, Oxford University Press
FOYE’S PRINCIPLES OF MEDICINAL CHEMISTRY 6TH EDITION
Medicinal Chemistry and Drug Design